Nephrogenic adenoma of the bladder in renal transplant recipients: a report of 9 cases with assessment of deoxyribonucleic acid ploidy and long-term followup.
OBJECTIVE
We evaluated the outcome of nephrogenic adenoma, a benign tumor rarely encountered in renal transplant recipients.


METHODS
Between 1985 and 1993, 9 renal transplant recipients with a nephrogenic bladder adenoma removed by endoscopic resection were followed for 24 to 88 months (mean 40). Tumor deoxyribonucleic acid ploidy was assessed by flow cytometry at diagnosis and/or relapse.


RESULTS
The relapse rate was 88%. The tumors were diploid and of low proliferating potential, and showed no malignant transformation.


CONCLUSIONS
Our study confirms the lack of premalignant potential of nephrogenic adenomas. However, since transplant recipients might be at increased risk for bladder cancer, they should be followed closely.
Fournier
G
G
Department of Urology, Centre Hospitalier et Universitaire A. Morvan, Brest, France.
Menut
P
P
Moal
M C
MC
Hardy
E
E
Volant
A
A
Mangin
P
P
D000236:Adenoma / Q000209:etiology / Q000235:genetics*; D000328:Adult; D004273:DNA, Neoplasm / Q000032:analysis*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D016030:Kidney Transplantation / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D011003:Ploidies; D013997:Time Factors; D001749:Urinary Bladder Neoplasms / Q000209:etiology / Q000235:genetics*
D004273:DNA, Neoplasm